Structure and function of GC79/TRPS1, a novel androgen-repressible apoptosis gene

Apoptosis

Volumn 7, Issue 1, 2002, Pages 13-21

  Chang, Glenn T G ^a   Van den Bemd, G J C M ^a   Jhamai, M ^a   Brinkmann, A O ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Androgen independent; Apoptosis; GC79 TRPS1; Prostate cancer; Zinc finger protein

Indexed keywords

ANDROGEN; GENE PRODUCT; PROTEIN GC79 TRPS1; TRANSCRIPTION FACTOR GATA 1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

APOPTOSIS; CANCER CELL CULTURE; CASTRATION; GENE EXPRESSION; GENE FUNCTION; GENE REPRESSION; GENE STRUCTURE; GENETIC CODE; HORMONE ACTION; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; SHORT SURVEY;

ANDROGENS; ANIMALS; APOPTOSIS; DNA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTORS;

EID: 0036167044     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013504710343     Document Type: Short Survey

References (83)

1. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking
2. The endocrinology and developmental biology of the prostate
3. Adaption versus selection as the mechanism responsible for the relapse to prostatic cancer to androgen ablation therapy as studied in Dunning R-3327-H adenocarcinoma
4. Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells
5. Studies on prostate cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate
6. Activation of programmed cell death in the rat ventral prostate after castration
7. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation
8. Cell death: The significance of apoptosis
9. Expression of the proto-oncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
10. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer
11. Androgen-repressed messages in the rat ventral prostate
12. Induction of the TRPM-2 gene in cells undergoing programmed death
13. Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death
14. Expression and function of the leucine zipper protein par-4 in apoptosis
15. Cascade induction of c-fos, c-myc and heat shock 70 K transcripts during regression of the rat ventral prostate gland
16. Characterization of a zinc-finger protein and its association with apoptosis in prostate cancer cells
17. Autosomal-dominant transmission of the tricho-rhino-phalangeal syndrome. Report of 4 unrelated families, review of 60 cases
18. Trichorhinophalangeal syndrome, type I
19. Trichorhinophalangeal syndrome type III
20. Mutations in a new gene, encoding a zinc-finger protein, cause tricho-rhino-phalangeal syndrome type I
21. Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1)
22. Genotypic and phenotypic spectrum in tricho-rhino-phalangeal syndrome types I and III
23. Transcriptional repression and developmental functions of the atypical vertebrate GATA protein TRPS1
24. LNCaP model of human prostatic carcinoma
25. The human prostatic cancer cell line LNCaP and its derived sublines: An in vitro model for the study of androgen sensitivity
26. Differentially expressed genes in androgen-dependent and -independent prostate carcinomas
27. Identification of a gene on human chromosome 8q11, that is differentially expressed during prostate cancer progression
28. Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer
29. Identification and characterization of genes involved in the progression of prostate cancer
30. An analysis of vertebrate mRNA sequences: Intimations of translational control
31. Xenopus 5S gene transcription factor TFIIIA: Characterization of a cDNA clone and measurement of RNA levels throughout development
32. Regulation of the Drosophila segmentation gene hunchback by two maternal morphogenetic centres
33. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment
34. Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin
35. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development
36. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation
37. Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin
38. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors
39. Eos, pegasus, two members of the ikaros family of proteins with distinct DNA binding activities
40. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes
41. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes
42. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation
43. Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity
44. GATA-binding transcription factors in hematopoietic cells
45. GATA transcription factors and cardiac development
46. GATA zinc finger interactions modulate DNA binding and transactivation
47. The zinc finger-containing transcription factors GATA-4, -5, and -6
48. Molecular evolution of the GATA family of transcription factors: Conservation within the DNA-binding domain
49. The genetics of Wilms' tumor: A case of disrupted development
50. GATA4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut
51. Function of GATA transcription factors in preadipocyte-adipocyte transition
52. Developmental stageand spermatogenic cycle-specific expression of transcription factor GATA-1 in mouse Sertoli cells
53. Mouse GATA-4: A retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart
54. Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary
55. Transcription factors GATA-4 and GATA-6 and a GATA family cofactor, FOG-2, are expressed in human ovary and sex cord-derived ovarian tumors
56. Expression and regulation of transcription factors GATA-4 and GATA-6 in developing mouse testis
57. Expression of transcription factor GATA-4 during human testicular development and disease
58. Rescue of the embryonic lethal hematopoietic defect reveals a critical role for GATA-2 in urogenital development
59. Localization of distant urogenital system-, central nervous system-, and endocardium-specific transcriptional regulatory elements in the GATA-3 locus
60. Abnormalities of the genitourinary tract in female mice lacking GATA5
61. GATA-3 is expressed in association with estrogen receptor in breast cancer
62. Transcription factor GATA-4 is expressed in pediatric yolk sac tumors
63. Testicular GATA-1 factor regulates the promoter activity of rat inhibin α-subunit in MA-10 Leydig tumor cells
64. GATA-1 and GATA-4 transactivate inhibin/activin beta-B-subunit gene transcription in testicular cells
65. A role for GATA transcription factors in the androgen regulation of the prostate-specific antigen gene enhancer
66. GATA factors are essential for activity of the neuron-specific enhancer of the gonadotropin-releasing hormone gene
67. The chicken vitellogenin II gene is flanked by a GATA factor-dependent estrogen response unit
68. CCAAT enhancer-binding protein beta and GATA-4 binding regions within the promoter of the steroidogenic acute regulatory protein (StAR) gene are required for transcription in rat ovarian cells
69. Transcription factor GATA-4 is expressed in a sexually dimorphic pattern during mouse gonadal development and is a potent activator of the Müllerian inhibiting substance promoter
70. Transcription factor GATA-4 enhances Müllerian inhibiting substance gene transcription through a direct interaction with the nuclear receptor SF-1
71. Endogenous expression of Müllerian inhibiting substance in early postnatal rat sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites
72. GATA-1 is a potential repressor of anti-Müllerian hormone expression during the establishment of puberty in the mouse
73. Steroidogenic factor-1 regulates transcription of the human anti-Müllerian hormone receptor
74. Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor
75. Inhibition of mouse GATA-1 function by the glucocorticoid receptor: Possible mechanism of steroid inhibition of erythroleukemia cell differentiation
76. Negative regulation of chicken GATA-1 promoter activity mediated by a hormone response element
77. Expression of maspin in prostate cells is regulated by a positive ets element and a negative hormonal responsive element site recognized by androgen receptor
78. Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen mibolerone
79. Mechanisms of apoptosis by c-myc
80. Expression of the c-myc protooncogen in human prostatic carcinoma and benign prostatic hyperplasia
81. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization
82. Clinical significance of alterations of chromosome 8 in high-grade, advanced, non-metastatic prostate carcinoma
83. Apoptosis: Translating theory to therapy for prostate cancer